Drug Information

Drug General Information
Drug ID
D0P7VJ
Former ID
DIB001594
Drug Name
Pramiracetam
Synonyms
Amacetam; Ectapram; Neupramir; Remen; Amacetam hydrochloride; Amacetam sulfate; Pramiracetam hydrochloride; Pramiracetam sulfate; CNS-1879
Drug Type
Small molecular drug
Indication Brain diseases [ICD10:G00-G99] Approved (orphan drug) [551871]
Company
Warner-Lambert Co
Formula
C14H28ClN3O2
Canonical SMILES
N1(C(=O)CCC1)CC(=O)NCCN(C(C)C)C(C)C
PubChem Compound ID
3050410
Target and Pathway
Target(s) Acetylcholine receptor Target Info Modulator [550025], [551871]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Muscarinic acetylcholine receptors
Acetylcholine regulates insulin secretion
Highly sodium permeable acetylcholine nicotinic receptors
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
WikiPathways Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 550025Some neurochemical properties of pramiracetam (CI-879), a new cognition-enhancing agent. Article first published online: 5 OCT 2004.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.